| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Lorand L | |
| P2860 | cites work | Transglutaminase: remembering Heinrich Waelsch | Q48736360 |
| Labeling of amine-acceptor cross-linking sites of fibrin by transpeptidation. | Q54623782 | ||
| Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin. | Q54787975 | ||
| Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms | Q28215367 | ||
| Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin | Q28245806 | ||
| Amino acid sequence of the a subunit of human factor XIII | Q28287928 | ||
| Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis | Q28589061 | ||
| Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments | Q28630727 | ||
| Treatment of heparin-induced thrombocytopenia: a critical review | Q33359690 | ||
| Sol Sherry Lecture in Thrombosis : research on clot stabilization provides clues for improving thrombolytic therapies | Q33817201 | ||
| Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity | Q34014137 | ||
| A pathological inhibitor of fibrin cross-linking | Q34271853 | ||
| Association of the A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma | Q34362826 | ||
| Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 | ||
| A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa | Q35739203 | ||
| Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases | Q36689540 | ||
| Fibrino-peptide | Q41953099 | ||
| Inhibition of protein cross-linking in Ca2+-enriched human erythrocytes and activated platelets | Q42161366 | ||
| The action of thrombin on fibrinogen. | Q42189018 | ||
| Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets | Q44155386 | ||
| Amine specificity in transpeptidation. Inhibition of fibrin cross-linking | Q44251111 | ||
| Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency | Q44706166 | ||
| Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase | Q47854610 | ||
| A peptide released from plasma fibrin stabilzing factor in the conversion to the active enzyme by thrombin | Q47944637 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1337-1348 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Factor XIII and the clotting of fibrinogen: from basic research to medicine | |
| P478 | volume | 3 |
| Q41967637 | A constitutive model for the time-dependent, nonlinear stress response of fibrin networks. |
| Q38052068 | Acquired FXIII inhibitors: a systematic review |
| Q48643585 | Association of perioperative factor XIII activity levels and other haemostatic markers with the risk of postoperative intracranial haematoma in a selected cohort of neurosurgical patients. |
| Q53367600 | Coagulation factor XIII variants with altered thrombin activation rates. |
| Q41825512 | Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot |
| Q38808158 | Diagnosis of factor XIII deficiency |
| Q34561268 | Factor XIII: recommended terms and abbreviations |
| Q45207763 | Interferon-γ, interleukins-6 and -4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis. |
| Q90444170 | Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a) |
| Q30997344 | Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. |
| Q53589389 | Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin. |
| Q51015788 | Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening. |
| Q37259580 | Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer. |
| Q42103946 | Reversible activation of cellular factor XIII by calcium |
| Q33959050 | Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation. |
| Q31063390 | Site-specific protein propargylation using tissue transglutaminase. |
| Q30541840 | Strain history dependence of the nonlinear stress response of fibrin and collagen networks |
| Q27687108 | Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulants |
| Q90388919 | Structure-Based Design of FXIIIa-Blockers: Addressing a Transient Hydrophobic Pocket in the Active Site of FXIIIa |
| Q44510667 | Synthesis and functional characterization of tridegin and its analogues: inhibitors and substrates of factor XIIIa |
| Q33375024 | The effect of fibrinogen concentrate on thrombocytopenia |
| Q24297406 | The fibrinogen Aalpha R16C mutation results in fibrinolytic resistance |
| Q27490448 | The role of saliva in tick feeding |
| Q35856363 | Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: relevance for erythrocyte diseases with shortened cell lifespan. |
| Q41791459 | Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. |
Search more.